Atlas Trials

EMaBS TB Vaccine Study

Clinical trial NCT03681860 · COMPLETED

Trial details

NCT number
NCT03681860
Sponsor
University of Oxford
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
SafetyImmunogenicity
Start date
2019-07-01
Primary completion
2021-05-24
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.